Suppr超能文献

抗菌药物管理在新冠疫情期间三级医疗机构中调节抗生素使用及减轻细菌耐药性方面的作用

Role of Antimicrobial Stewardship in Modulating Antibiotic Use and Mitigating Bacterial Resistance in a Tertiary Care Setting During COVID-19.

作者信息

Zhang Xueyan, Zhou Lijuan, Peng Pingzhi, Zhang Weiquan, Liang Chunhong

机构信息

Department of Pharmacy, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, 537000, People's Republic of China.

Office of Drug Clinical Trial Institution, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, 537000, People's Republic of China.

出版信息

Infect Drug Resist. 2025 Mar 29;18:1647-1656. doi: 10.2147/IDR.S500379. eCollection 2025.

Abstract

PURPOSE

Despite the widespread adoption of antimicrobial stewardship (AMS) programs, their effectiveness varies because of differing regional policies and socioeconomic factors. This study aimed to assess the impact of AMS at a Chinese tertiary care hospital on inpatient antimicrobial use and bacterial resistance during the COVID-19 outbreak.

METHODS

An interrupted time-series regression analysis was conducted to compare inpatient antimicrobial use between pre- and post-intervention periods. The Chi-squared test and linear regression analysis were used to compare bacterial resistance and illustrate temporal trends in bacterial resistance, respectively.

RESULTS

Following the AMS strategy implementation, we observed a significant decrease in antimicrobial consumption at unrestricted (β2 = -6.38, P = 0.004), restricted (β2 = -17.81, P < 0.001), and special levels (β2 = -2.32, P < 0.001). Despite a reduction in the use of third-generation cephalosporins and macrolides (β2 = -6.85, P < 0.001; β2 = -2.82, P < 0.001), an increase in the trend of use was observed post-intervention (β3 = 0.15, P < 0.001; β3 = 0.04, P = 0.001). Methicillin resistance in significantly decreased (β = -0.23, P < 0.001) from 52.85% to 40.92%. Conversely, the prevalence of carbapenem-resistant increased from 4.69% to 10.87% (P < 0.001), whereas resistance to and marginally decreased (P<0.05). We observed decreases in the antimicrobial utilization rate (β2 = -11.86, P = 0.003) and combination utilization rate (β2 = -12.36, P = 0.011) post-intervention. No significant changes in special-level antimicrobial and prophylactic agent use in category I incisional surgeries were observed.

CONCLUSION

An AMS program in a Chinese tertiary facilitated effective management of antimicrobial use and reduction of bacterial resistance during the COVID-19 pandemic, in the context of combined infection prevention and control measures. The findings provide useful insights for the implementation of antimicrobial stewardship in future public health crises.

摘要

目的

尽管抗菌药物管理(AMS)计划已广泛采用,但其有效性因地区政策和社会经济因素的不同而有所差异。本研究旨在评估中国一家三级医疗机构的AMS计划在新冠疫情期间对住院患者抗菌药物使用及细菌耐药性的影响。

方法

采用中断时间序列回归分析比较干预前后住院患者的抗菌药物使用情况。分别使用卡方检验和线性回归分析比较细菌耐药性并阐明细菌耐药性的时间趋势。

结果

实施AMS策略后,我们观察到非限制级(β2 = -6.38,P = 0.004)、限制级(β2 = -17.81,P < 0.001)和特殊使用级(β2 = -2.32,P < 0.001)抗菌药物的消耗量均显著下降。尽管第三代头孢菌素和大环内酯类药物的使用量有所减少(β2 = -6.85,P < 0.001;β2 = -2.82,P < 0.001),但干预后使用趋势有所增加(β3 = 0.15,P < 0.001;β3 = 0.04,P = 0.001)。金黄色葡萄球菌的耐甲氧西林率从52.85%显著下降至40.92%(β = -0.23,P < 0.001)。相反,耐碳青霉烯类肺炎克雷伯菌的患病率从4.69%升至10.87%(P < 0.001),而对铜绿假单胞菌和鲍曼不动杆菌的耐药性略有下降(P<0.05)。我们观察到干预后抗菌药物使用率(β2 = -11.86,P = 0.003)和联合使用率(β2 = -12.36,P = 0.011)均有所下降。在I类切口手术中,特殊使用级抗菌药物和预防用抗菌药物的使用未观察到显著变化。

结论

在中国一家三级医疗机构实施的AMS计划,在联合感染预防与控制措施的背景下,有助于在新冠疫情期间有效管理抗菌药物使用并降低细菌耐药性。这些研究结果为未来公共卫生危机中实施抗菌药物管理提供了有益的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f87/11963796/e2d868676189/IDR-18-1647-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验